Trademark: 85693119
Status Date
Friday, April 2, 2021
Registration Number
4591003
Registration Date
Tuesday, August 26, 2014
Filing Date
Wednesday, August 1, 2012
Published for Opposition
Tuesday, October 29, 2013
Cancellation Date
Friday, April 2, 2021
1 Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
5 Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
10 Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, empty vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
42 Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy
Apr 2, 2021
Cancelled Sec. 8 (6-Yr)
Aug 26, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 8, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 8, 2018
Teas Change Of Owner Address Received
Jun 8, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 8, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 26, 2014
Registered-Principal Register
Jul 22, 2014
1(B) Basis Deleted; Proceed To Registration
Jun 23, 2014
Notice Of Allowance Cancelled
Jul 14, 2014
Case Assigned To Intent To Use Paralegal
Jun 23, 2014
Teas Post Publication Amendment Received
Dec 24, 2013
Noa E-Mailed - Sou Required From Applicant
Oct 29, 2013
Official Gazette Publication Confirmation E-Mailed
Oct 29, 2013
Published For Opposition
Oct 9, 2013
Notification Of Notice Of Publication E-Mailed
Sep 25, 2013
Law Office Publication Review Completed
Sep 24, 2013
Approved For Pub - Principal Register
Sep 24, 2013
Teas/Email Correspondence Entered
Sep 24, 2013
Correspondence Received In Law Office
Sep 17, 2013
Teas Response To Office Action Received
Aug 5, 2013
Notification Of Non-Final Action E-Mailed
Aug 5, 2013
Non-Final Action E-Mailed
Aug 5, 2013
Non-Final Action Written
Aug 2, 2013
Previous Allowance Count Withdrawn
Jul 29, 2013
Approved For Pub - Principal Register
Jul 29, 2013
Teas/Email Correspondence Entered
Jul 29, 2013
Correspondence Received In Law Office
Jul 22, 2013
Assigned To Lie
Jul 18, 2013
Teas Response To Office Action Received
Jan 21, 2013
Notification Of Non-Final Action E-Mailed
Jan 21, 2013
Non-Final Action E-Mailed
Jan 21, 2013
Non-Final Action Written
Jan 9, 2013
Previous Allowance Count Withdrawn
Dec 16, 2012
Withdrawn From Pub - Og Review Query
Nov 29, 2012
Approved For Pub - Principal Register
Nov 28, 2012
Assigned To Examiner
Aug 10, 2012
New Application Office Supplied Data Entered In Tram
Aug 4, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
